Literature DB >> 9563494

Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis.

V W Yang1, J M Shields, S R Hamilton, E W Spannhake, W C Hubbard, L M Hylind, C R Robinson, F M Giardiello.   

Abstract

Recent studies indicate that nonsteroidal anti-inflammatory drugs have a chemopreventive effect against colorectal neoplasia. Nonsteroidal anti-inflammatory drugs inhibit cyclooxygenases, principal enzymes that mediate the formation of prostanoids. To determine whether prostanoids are involved in the pathogenesis of colorectal adenomas, we compared the levels of five major stable metabolic products of the cyclooxygenase pathway in the normal-appearing mucosa and in adenomas of patients with familial adenomatosis polyposis. Of 12 patients tested, 6 had elevated levels of at least one prostanoid in the adenomas. More importantly, the relative levels of three prostanoids [prostaglandin (PG)D2, PGE2, and 6-keto-PGF1alpha] were elevated in adenomas compared to normal-appearing mucosa from the same patients, and the resulting ratios were correlated with the size of the adenoma. These results suggest a role for prostanoids in progression of colorectal polyposis in familial adenomatosis polyposis patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563494

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.

Authors:  Martha J Shrubsole; Qiuyin Cai; Wanqing Wen; Ginger Milne; Walter E Smalley; Zhi Chen; Reid M Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-13

2.  Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.

Authors:  Anita Jerome-Morais; Margaret E Wright; Rui Liu; Wancai Yang; Matthew I Jackson; Gerald F Combs; Alan M Diamond
Journal:  Prostate       Date:  2011-11-09       Impact factor: 4.104

3.  Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.

Authors:  T I Kim; Y C Lee; K H Lee; J H Han; C Y Chon; Y M Moon; J K Kang; I S Park
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 4.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

5.  Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.

Authors:  Altaf Mohammed; Naveena B Janakiram; Qian Li; Chang-In Choi; Yuting Zhang; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-01

Review 6.  The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.

Authors:  Margaret Cho; Janell Carter; Saul Harari; Zhiheng Pei
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

7.  The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.

Authors:  Inok Surh; Joyce E Rundhaug; Amy Pavone; Carol Mikulec; Erika Abel; Melissa Simper; Susan M Fischer
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

8.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

9.  The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.

Authors:  Cyril Sobolewski; Claudia Cerella; Mario Dicato; Lina Ghibelli; Marc Diederich
Journal:  Int J Cell Biol       Date:  2010-03-17

10.  The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Authors:  Yasmin Hernandez; John Sotolongo; Keith Breglio; Daisy Conduah; Anli Chen; Ruliang Xu; David Hsu; Ryan Ungaro; Lory A Hayes; Cristhine Pastorini; Maria T Abreu; Masayuki Fukata
Journal:  BMC Gastroenterol       Date:  2010-07-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.